Award
National Cancer Institute 5R01CA292925-02
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH)
Awarded
September 05, 2025
Identifier
5R01CA292925-02
Research project by NIH/NCI studying factors affecting adherence to oral anticancer medication in hematologic malignancy patients to improve health outcomes.
Description
This is a research project funded by the NIH/NCI focusing on medication adherence in patients with hematologic malignancies. The project involves data collection, analysis, and development of interventions to improve health outcomes.